Log In
Saturday 24th August 2019

GSK invests £500m in UK

22nd March 2012

Drug manufacturer GlaxoSmithKline is set to invest £500m in manufacturing in the UK.

Plans include building a new factory in Ulverston, Cumbria, in investments which could create up to 1,000 new jobs and see the biopharmaceutical facility be the first new UK factory for Glaxo in 40 years. Glaxo said it was “one of the largest commitments to the UK life-sciences sector in recent years” and was motivated by tax rules announced by Chancellor George Osborne in his budget. But it will not be up and running until at least 2020.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2019